Alignment Healthcare (NASDAQ:ALHC) President Dawn Christine Maroney Sells 122,707 Shares of Stock

by · The Markets Daily

Alignment Healthcare, Inc. (NASDAQ:ALHC – Get Free Report) President Dawn Maroney sold 122,707 shares of the business’s stock in a transaction dated Friday, September 11th. The shares were sold at an average price of $12.68, for a total transaction of $1,555,924.76. Following the sale, the president directly owned 794,606 shares of the company’s stock, valued at approximately $10,075,604.08. This represents a 13.38% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Dawn Christine Maroney also recently made the following trade(s):

  • On Monday, June 15th, Dawn Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $19.55, for a total transaction of $586,500.00.

Alignment Healthcare Stock Performance

Shares of NASDAQ:ALHC traded down $0.15 during trading on Friday, hitting $12.61. 6,075,652 shares of the company traded hands, compared to its average volume of 3,839,666. The company has a quick ratio of 1.70, a current ratio of 1.70 and a debt-to-equity ratio of 1.22. The business’s fifty day moving average is $16.17 and its 200-day moving average is $18.03. The stock has a market capitalization of $2.62 billion, a price-to-earnings ratio of 66.37 and a beta of 1.11. Alignment Healthcare, Inc. has a one year low of $12.39 and a one year high of $25.12.

Alignment Healthcare (NASDAQ:ALHC – Get Free Report) last announced its quarterly earnings results on Thursday, July 30th. The company reported $0.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.13 by $0.04. Alignment Healthcare had a return on equity of 20.02% and a net margin of 0.89%.The business had revenue of $1.34 billion for the quarter, compared to the consensus estimate of $1.31 billion. During the same quarter last year, the business posted $0.07 EPS. The business’s revenue was up 31.6% on a year-over-year basis. As a group, equities analysts predict that Alignment Healthcare, Inc. will post 0.17 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. Allworth Financial LP increased its stake in Alignment Healthcare by 8.9% during the 4th quarter. Allworth Financial LP now owns 6,917 shares of the company’s stock valued at $137,000 after buying an additional 566 shares during the period. Integrated Wealth Concepts LLC raised its position in shares of Alignment Healthcare by 6.3% during the 3rd quarter. Integrated Wealth Concepts LLC now owns 11,230 shares of the company’s stock worth $196,000 after buying an additional 665 shares in the last quarter. Parallel Advisors LLC lifted its stake in shares of Alignment Healthcare by 87.7% in the 4th quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock worth $33,000 after acquiring an additional 773 shares during the period. Tidal Investments LLC lifted its stake in shares of Alignment Healthcare by 4.9% in the 2nd quarter. Tidal Investments LLC now owns 18,094 shares of the company’s stock worth $253,000 after acquiring an additional 852 shares during the period. Finally, PNC Financial Services Group Inc. boosted its holdings in shares of Alignment Healthcare by 9.2% in the first quarter. PNC Financial Services Group Inc. now owns 11,445 shares of the company’s stock valued at $202,000 after acquiring an additional 962 shares in the last quarter. 86.19% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on ALHC shares. KeyCorp restated an “overweight” rating on shares of Alignment Healthcare in a research report on Wednesday, June 10th. Barclays reduced their target price on shares of Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating for the company in a research note on Tuesday, May 26th. Weiss Ratings restated a “hold (c-)” rating on shares of Alignment Healthcare in a research report on Tuesday, August 4th. Zacks Research lowered shares of Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 6th. Finally, UBS Group reaffirmed a “neutral” rating on shares of Alignment Healthcare in a report on Wednesday, July 8th. Seven research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $23.60.

Get Our Latest Analysis on ALHC

About Alignment Healthcare

(Get Free Report)

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.

Featured Articles